Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOPPIT: PPI Discontinuation in Liver Cirrhosis
NCT04448028Phase 4Recruiting
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Apr 2021
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esomeprazole in upper gastrointestinal bleeding (UGIB), sponsored by University Medical Center Hamburg-Eppendorf. Started Apr 2021; status: recruiting.
02
Drugs
esomeprazole
03
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on NCT04448028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04448028.